Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.
Sponsor:
Medical University of South Carolina
Location:
Code:
NCT05095532
Conditions
Chronic Pancreatitis
Mesenchymal Stem Cells
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bone marrow-derived mesenchymal stem cells
Placebo
Sponsor:
Healios K.K.
Location:
Code:
NCT04533464
Conditions
Trauma
Adult Stem Cells
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MultiStem
Placebo
Sponsor:
MedRegen LLC
Location:
Code:
NCT04646603
Conditions
COVID-19
ARDS, Human
Stem Cells
Regeneration
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MRG-001
Placebo
Sponsor:
Marie Hudson, MD
Location:
Code:
NCT04356287
Conditions
Sclerosis, Systemic
Mesenchymal Stem Cells
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
UCMSC
Placebo
Sponsor:
First Institute of All Medicines
Location:
Code:
NCT06855459
Conditions
Increase the Total Number of Stem Cells
Inflammation
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Biophoton Generators
Get alerts for new trials in your area by subscribing now
Sponsor:
Stanford University
Location:
Code:
NCT05088356
Conditions
Allogeneic Hematopoietic Cell Transplantation (HCT)
Advanced Hematologic Malignancies
Acute Leukemia
Chronic Myelogenous Leukemia
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Purified regulatory T-cells (Treg) plus CD34+ HSPC
Fludarabine
Melphalan
CliniMACS CD34 Reagent System
Tacrolimus
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT02390752
Conditions
Neurofibroma, Plexiform
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Promyelocytic, Acute
Sarcoma
Eligibility Criteria
Sex: All
Age: 3 - 35
Healthy Volunteers: Not accepted
Interventions
TURALIO(R)
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT05775718
Conditions
Bone Marrow Transplant
Stem Cell Transplant
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Zoster Vaccine Recombinant
Sponsor:
Dana-Farber Cancer Institute
Location:
Code:
NCT06468618
Conditions
Stem Cell Transplant Complications
Sleep Disturbance
Eligibility Criteria
Sex: All
Age: 9 - 17
Healthy Volunteers: Not accepted
Interventions
DREAMS Program Video and Care Kit
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05436418
Conditions
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Accepted
Interventions
Melphalan
Sirolimus
Total Body Irradiation (TBI)
Cyclophosphamide
Mycophenolate Mofeti
Stem cell clinical trials are research studies that explore the therapeutic potential of stem cells for treating a wide range of diseases and conditions. These trials investigate various types of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and adipose-derived stem cells. These trials aim to develop treatments for a wide range of conditions, such as cardiovascular diseases, neurological disorders, autoimmune diseases, orthopedic injuries, Alzheimer's disease, Crohn's disease and cancer.
Clinical trials for stem cells are crucial for advancing regenerative medicine and offering hope for patients with conditions that are currently difficult to treat. These studies help to determine the safety, efficacy, and optimal use of stem cell therapies, potentially leading to breakthroughs in the treatment of chronic diseases, immune disorders, and injuries. They play a vital role in understanding how stem cells can be used to repair damaged tissues, treat malignancies, and improve patient outcomes.
Stem cell clinical trials investigate a variety of interventions aimed at utilizing the unique properties of stem cells for therapeutic purposes. Some common types of interventions studied in stem cell clinical trials include:
These trials assess the use of stem cells derived from both the patient (autologous) and donors (allogeneic) for the treatment of hematologic diseases, solid tumors, and immune disorders, aiming to restore normal cell function and immune response.
Some trials focus on using stem cells to replace or repair damaged or dysfunctional cells or tissues in the body. For example, mesenchymal stem cells (MSCs) may be used to regenerate bone, cartilage, or muscle tissue in orthopedic conditions, while hematopoietic stem cell transplants are used to replace damaged blood-forming cells in conditions such as leukemia or aplastic anemia.
Clinical trials are investigating stem cells for their potential to stimulate tissue regeneration and repair. This includes approaches such as seeding stem cells onto scaffolds or matrices to create tissue-engineered constructs for transplantation. Research includes developing bioengineered tissues and organs using stem cells to replace damaged tissues in conditions like Crohn's disease-related fistulas, cartilage defects, and chronic pancreatitis.
Gene-modified stem cell therapies are being investigated for their potential in treating genetic disorders, metabolic diseases, and certain types of cancer. For example, genetically modified hematopoietic stem cells may be used to treat inherited blood disorders like sickle cell disease or beta-thalassemia.
Clinical trials are studying stem cell therapies for their potential to protect and regenerate neurons in neurodegenerative diseases and neurological injuries. This includes approaches such as transplantation of neural stem cells or mesenchymal stem cells, as well as promoting endogenous neurogenesis and synaptic repair.
Eligibility for stem cells clinical trials varies widely, targeting specific diseases, age groups, and health conditions. Trials may be open to individuals with specific diagnoses, such as leukemia, Alzheimer's disease, or organ-specific injuries. Criteria often include the stage of the disease, previous treatments, and overall health status.
Participants can expect thorough screening for eligibility, comprehensive information about the study's purpose and procedures, and close monitoring throughout the trial. This may involve receiving stem cell infusions, undergoing surgical procedures for tissue transplantation, and participating in follow-up assessments to monitor the therapy's effectiveness and any side effects.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Enrolling in a stem cell clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: